Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis

被引：0
|
作者：
Bradley A. Warady
Eric Ng
Laura Bloss
May Mo
Franz Schaefer
Justine Bacchetta
机构：
[1] Children’s Mercy Kansas City,Division of Pediatric Nephrology
[2] Amgen Inc.,undefined
[3] Heidelberg University Hospital,undefined
[4] Department of Pediatric Nephrology,undefined
[5] Rheumatology and Dermatology,undefined
[6] Femme Mère Enfant Hospital,undefined
来源：
Pediatric Nephrology | 2020年 / 35卷
关键词：
Cinacalcet; CKD-MBD; Dialysis; Pediatric; sHPT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1679 / 1697
页数：18
相关论文
共 50 条
  • [21] A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis
    Warady, Bradley A.
    Iles, Janet N.
    Ariceta, Gema
    Dehmel, Bastian
    Hidalgo, Guillermo
    Jiang, Xun
    Laskin, Benjamin
    Shahinfar, Shahnaz
    Vande Walle, Johan
    Schaefer, Franz
    PEDIATRIC NEPHROLOGY, 2019, 34 (03) : 475 - 486
  • [22] A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis
    Bradley A. Warady
    Janet N. Iles
    Gema Ariceta
    Bastian Dehmel
    Guillermo Hidalgo
    Xun Jiang
    Benjamin Laskin
    Shahnaz Shahinfar
    Johan Vande Walle
    Franz Schaefer
    Pediatric Nephrology, 2019, 34 : 475 - 486
  • [23] Dosing of Etelcalcetide and Cinacalcet for Secondary Hyperparathyroidism
    Hai, Mary T. Thanh
    Guettier, Jean-Marc
    Rosebraugh, Curtis J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (20): : 2132 - 2132
  • [24] Cinacalcet Treatment for Secondary Hyperparathyroidism in Dialysis Patients: An Observational Study in Routine Clinical Practice
    Bover, Jordi
    Perez, Rafael
    Molina, Manuel
    Benavides, Beatriz
    Ariza, Francisco
    Luis Miguel, Jose
    Tornero, Fernando
    Vicens Torregrosa, Josep
    NEPHRON CLINICAL PRACTICE, 2011, 118 (02): : C109 - C121
  • [25] USEFULNESS OF RADIOLOGIC EVALUATION TO PREDICT THE RESPONSE OF CINACALCET TREATMENT IN SECONDARY HYPERPARATHYROIDISM OF DIALYSIS PATIENTS
    Ah, Hong Yu
    Jee, Ko Gang
    Yeon, Jung Mi
    Sun, Cho Yoo
    Young, Oh Soo
    Hee, Seo Jae
    Jung, Pyo Heui
    Sangil, Suh
    Joo, Kwon Young
    NEPHROLOGY, 2014, 19 : 131 - 132
  • [26] Cinacalcet for secondary hyperparathyroidism in ESRD patients
    Kirby R.
    Nature Clinical Practice Nephrology, 2006, 2 (1): : 8 - 9
  • [27] SPONTANEOUS REMISSION OF SECONDARY HYPERPARATHYROIDISM IN PATIENT RECEIVING REGULAR DIALYSIS
    AHMAD, R
    RAICHURA, N
    GOLDSMITH, HJ
    BRITISH MEDICAL JOURNAL, 1982, 284 (6314): : 469 - 469
  • [28] Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients
    Owda, AK
    Alam, MG
    Kumar, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (02): : 188 - 188
  • [29] Cinacalcet use and risk of gastrointestinal bleeding in secondary hyperparathyroidism patients receiving maintenance hemodialysis
    Lin, Tzu-Chieh
    Guo, Haifeng
    Dluzniewski, Paul
    Peng, Yi
    Gilbertson, Dave
    Bradbury, Brian
    Nieman, Kimberly
    Sprafka, Michael
    Liu, Jiannong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 573 - 574
  • [30] Impact of Vitamin D Dose on Biochemical Parameters in Patients with Secondary Hyperparathyroidism Receiving Cinacalcet
    Wilkie, Martin
    Pontoriero, Giuseppe
    Macario, Fernando
    Yaqoob, Magdi
    Bouman, Koen
    Braun, Johann
    von Albertini, Beat
    Brink, Hans
    Maduell, Francisco
    Graf, Helmut
    Frazao, Joao M.
    Bos, Willem Jan
    Torregrosa, Vicente
    Saha, Heikki
    Reichel, Helmut
    Zani, Valter J.
    Carter, Dave
    Messa, Piergiorgio
    NEPHRON CLINICAL PRACTICE, 2009, 112 (01): : C41 - C50
12345